| Severe hepatotoxicity of mithramycin therapy caused by altered expression of hepatocellular bile transporters TM Sissung, PA Huang, RJ Hauke, EM McCrea, CJ Peer, RH Barbier, ... Molecular pharmacology 96 (2), 158-167, 2019 | 29 | 2019 |
| Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3p RH Barbier, EM McCrea, KY Lee, JD Strope, EN Risdon, DK Price, ... Scientific reports 11 (1), 10765, 2021 | 12 | 2021 |
| Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA)n Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors? TM Sissung, RH Barbier, DK Price, TM Plona, KM Pike, SD Mellott, ... International Journal of Molecular Sciences 21 (3), 896, 2020 | 8 | 2020 |
| UGT1A1 Polymorphisms and Mutations Affect Anticancer Drug Therapy TM Sissung, R Barbier, LM Cordes, WD Figg Handbook of Therapeutic Biomarkers in Cancer, 407-454, 2021 | 3 | 2021 |
| Androgen receptor splice variant 7 (AR-V7) and AR full-length (AR-FL) as predictive biomarkers of therapeutic resistance: partners in crime? RH Barbier, CH Chau, WD Figg BJU international 124 (4), 549, 2019 | 2 | 2019 |
| Abstract A069: Mechanisms governing the transcriptional regulation of the liver-specific transporter OATP1B3 in prostate cancer RH Barbier, EM McCrea, JD Strope, PA Huang, TM Sissung, DK Price, ... Molecular Cancer Therapeutics 18 (12_Supplement), A069-A069, 2019 | | 2019 |
